Diet drug improves metabolic risk factors

November 24, 2005

A study suggests that Rimonabant, a drug that helps people lose weight by blocking pleasure centers in the brain also significantly improves metabolic risk factors in overweight people at increased risk of cardiovascular disease. The selective cannabinoid-1 receptor blocker, significantly reduces body weight, waist circumference and various other risk factors in overweight patients with dyslipidaemia.

The findings also suggested that the drug reduced metabolic risk independently of weight loss. Though the drug is immensely beneficial for weight loss but in can lead to side effects like depression, anxiety and nausea. For better results, the need for careful safety assessment of weight-loss drugs has been stressed to avoid its misuse.

Read the complete news article here:
http://news.australiandoctor.com.au